Migraine drugs

Drugmakers that develop and sell medicines to prevent or treat migraine attacks.
+20.4%
over 3 months · S&P 500 −2.1%

Key indicators

Health
51 / 100
Fragile
Solid
Price
P/E 51
Cheap
Expensive
Up over 1 year
4 of 7
Wallets over 90 days
1 / 2 buys / sells
Buys
Sells
Health and price: against the other tags.